Pegunigalsidase alfa
PB-102-F50
Phase 3 mab completed
Quick answer
Pegunigalsidase alfa for Fabry Disease is a Phase 3 program (mab) at Protalix BioTherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Protalix BioTherapeutics
- Indication
- Fabry Disease
- Phase
- Phase 3
- Modality
- mab
- Status
- completed